Cite
HARVARD Citation
Sow, H. et al. (2019). FcγR interaction is not required for effective anti‐PD‐L1 immunotherapy but can add additional benefit depending on the tumor model. International journal of cancer. 144 (2), pp. 345-354. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sow, H. et al. (2019). FcγR interaction is not required for effective anti‐PD‐L1 immunotherapy but can add additional benefit depending on the tumor model. International journal of cancer. 144 (2), pp. 345-354. [Online].